Book a demo

Cut patent&paper research from weeks to hours with PatSnap Eureka AI!

Try now
Int’l Health Technology v. Enseo: MadeSafe Patent Dismissal | PatSnap
Explore in Eureka
Case ID2:24-cv-00010
FiledJan 2024
ClosedFeb 2025
Patent Litigation

Int’l Health Technology v. Enseo — MadeSafe Patent Dispute Resolved in 414 Days

International Health Technology Company, LLC asserted US7486194B2 — covering the MadeSafe safety and monitoring system — against hospitality technology provider Enseo, LLC in the Eastern District of Texas. The parties reached a resolution and filed a joint stipulation; plaintiff’s claims were dismissed with prejudice while Enseo’s counterclaims were dismissed without prejudice, with each side bearing its own costs.

Resolution time
414days
414-day lifespan — resolved before trial in E.D. Texas, where median patent case runs ~2 years
Patents asserted
1
US7486194B2 — MadeSafe system, safety and personnel monitoring technology
Outcome
Case Dismissed
Plaintiff’s claims dismissed with prejudice; defendant’s counterclaims dismissed without prejudice
Cost ruling
Own Costs
Each party bears its own costs, expenses, and attorneys’ fees — no fee-shifting ordered
Published by PatSnap Insights Team · Verified by PatSnap Eureka Data
Case overview

MadeSafe Patent Claim Ends in Prejudicial Dismissal for IHTC

On January 9, 2024, International Health Technology Company, LLC filed suit against Enseo, LLC in the U.S. District Court for the Eastern District of Texas (Case No. 2:24-cv-00010), asserting infringement of US7486194B2. The patent relates to the MadeSafe system, a safety and monitoring technology. Enseo is a provider of hospitality technology solutions, and the assertion suggests IHTC believed Enseo’s products or services overlapped with the protected technology.

The case closed on February 26, 2025, after 414 days, via a joint stipulation of dismissal. The court accepted the stipulation and dismissed all of IHTC’s claims with prejudice — meaning IHTC is permanently barred from re-asserting the same claims against Enseo on the same patent. Enseo’s counterclaims were dismissed without prejudice, preserving Enseo’s theoretical ability to re-raise those claims in future proceedings. Each party was ordered to bear its own litigation costs.

A resolution within 414 days — before trial — is consistent with a negotiated settlement, though the public record does not confirm whether any financial consideration changed hands. The split dismissal structure (plaintiff with prejudice, defendant without prejudice) is a notable asymmetry that typically signals the patent holder accepted terms unfavorable to future re-litigation. The underlying commercial terms, if any, remain confidential.

Case at a glance
Case no.2:24-cv-00010
DefendantEnseo, LLC
CourtTexas Eastern
JudgeN/A
FiledJanuary 9, 2024
ClosedFebruary 26, 2025
Duration414 days
OutcomeCase Dismissed
Verdict causeInfringement Action
BasisCase Dismissed
Prior Art Intelligence
See what prior art exists on this patent.
Eureka scans millions of patents and papers to surface prior art that may have invalidated these claims before costly litigation begins.
Check Prior Art
Case data sourced from PACER / Texas Eastern District Court via PatSnap Eureka Litigation Intelligence Explore similar cases ↗
Case timeline

Filing to Case Dismissed in 414 days

414-day lifespan — resolved before trial in E.D. Texas, where median patent case runs ~2 years

Case timeline: Complaint filed JAN 9 2024, AUG–SEP — 414 days total Horizontal timeline showing the three key events in International Health Technology Company, LLC v Enseo, LLC from filing to resolution. Source: PACER, Texas Eastern District Court. JAN 9 2024 Complaint filed Pre-trial proceedings FEB 26 2025 Case Dismissed 414 DAYS TOTAL
Dismissal terms

Joint stipulation dismissed: what the split outcome means for both parties

Legal mechanism

Joint stipulation ends the case — but terms are asymmetric

A joint stipulation of dismissal is a procedural mechanism by which both parties agree to end litigation without a court merits ruling. Here, the court accepted the stipulation under Federal Rule of Civil Procedure 41. The asymmetry — plaintiff’s claims dismissed with prejudice, defendant’s counterclaims without prejudice — is court-ordered and meaningful: it was not a neutral exit for both sides.

Rule 41 joint stipulation
Plaintiff outcome

IHTC permanently barred from re-asserting these claims against Enseo

Dismissal with prejudice of IHTC’s claims operates as a final adjudication on the merits for res judicata purposes. IHTC cannot file a new suit against Enseo asserting the same infringement theories under US7486194B2. This is a significant concession by the patent holder — it forecloses future enforcement against this specific defendant regardless of future product developments by Enseo.

Claims extinguished vs. Enseo
Defendant outcome

Enseo’s counterclaims survive — dismissed without prejudice

Enseo’s counterclaims — which commonly include invalidity or non-infringement defenses asserted as affirmative claims — were dismissed without prejudice. This means Enseo retains the right to re-raise those counterclaims in future proceedings if circumstances require. The preservation of Enseo’s counterclaims, combined with each party bearing its own fees, suggests Enseo negotiated from a position of relative strength.

Counterclaims preserved
Commercial implications

No fee-shifting and split dismissal suggests a negotiated resolution

The ‘each party bears its own costs’ order and the asymmetric dismissal structure are consistent with a confidential settlement in which Enseo made limited or no financial concessions. For other market participants, this outcome suggests US7486194B2 may face enforceability challenges or that claim scope was contested. Companies in the hospitality technology and safety monitoring space should note that the patent remains in force against third parties.

Patent still enforceable vs. others
Legal analysis based on PACER docket records for case 2:24-cv-00010 and PatSnap Eureka litigation intelligence Search PatSnap Eureka ↗
Parties and representation

Full party and counsel information

RoleNameTypeDetail
PlaintiffInternational Health Technology Company, LLCCompanySafety and monitoring technology licensor — holder of US7486194B2 (MadeSafe system)Search in Eureka ↗
DefendantEnseo, LLCCompanyHospitality technology solutions provider — target of MadeSafe system infringement claimSearch in Eureka ↗
Plaintiff counselCortney AlexanderAttorneyCounsel for International Health Technology Company, LLCSearch in Eureka ↗
Plaintiff law firmKent & Risley LLC (Alpharett)Law FirmRepresenting International Health Technology Company, LLCSearch in Eureka ↗
Defendant counselLance Eric Wyatt , Jr.AttorneyCounsel for Enseo, LLCSearch in Eureka ↗
Defendant counselNan LanAttorneyCounsel for Enseo, LLCSearch in Eureka ↗
Defendant counselNeil J McNabnayAttorneyCounsel for Enseo, LLCSearch in Eureka ↗
Defendant law firmFish & Richardson LLPLaw FirmRepresenting Enseo, LLCSearch in Eureka ↗
Presiding judgeJudge N/AJudgeTexas Eastern District CourtSearch in Eureka ↗
Official verdict

Official order — verbatim text

“Before the Court is the Joint Stipulation of Dismissal filed by Plaintiff International Health Technology Company, LLC and Defendant Enseo, LLC. Dkt. No. 42. In the Stipulation, the parties represent that the above-captioned case has been resolved and request dismissal of the abovecaptioned action. Id. at 1. Having considered the Stipulation, the Court ACCEPTS AND ACKNOWLEDGES it. All claims that Plaintiff raised in this action are dismissed WITH PREJUDICE. All counterclaims that Defendant raised are dismissed WITHOUT PREJUDICE. Each party is to bear its own costs, expenses, and attorneys’ fees. All pending requests by Plaintiff for relief in the above-captioned member case not explicitly granted herein are DENIED AS MOOT. The Clerk of Court is directed to CLOSE the above-captioned lead case, as no other parties remain.”
Source: PACER Docket, Case 2:24-cv-00010, Texas Eastern District Court

The verdict text specifies a bifurcated dismissal: IHTC’s claims dismissed with prejudice, Enseo’s counterclaims without prejudice. This asymmetry is legally significant — with-prejudice dismissal of the plaintiff’s claims bars re-litigation under res judicata, while the without-prejudice counterclaim dismissal leaves Enseo’s defensive theories intact. The ‘each party bears its own costs’ order rules out any fee-shifting finding under 35 U.S.C. § 285, suggesting the court did not find the case exceptional in either party’s favor.

PACER case 2:24-cv-00010 · Public docket record Explore in Eureka ↗
Patent at issue

US7486194B2 — MadeSafe Safety and Personnel Monitoring System

Publication No.US7486194B2
Application No.US10/387121
Patent details
ProductMadeSafe safety and personnel monitoring system technology
Cited in actionJanuary 9, 2024

US7486194B2, filed under application number US10/387121, covers the MadeSafe system — a technology platform in the safety and personnel monitoring domain. The patent’s B2 designation indicates it issued following examination and has undergone post-grant correction. Its application date places its priority in an era predating widespread IoT integration in hospitality environments, which may affect claim scope relative to modern connected safety systems deployed by companies like Enseo.

For the hospitality technology sector, US7486194B2 represents a potential IP barrier for companies offering in-room safety, staff duress, or monitoring solutions. Enseo’s hospitality platform — which encompasses in-room entertainment and connected services — could intersect with personnel safety features. The patent remains in force and is enforceable against third parties not covered by this dismissal, making it a live risk for other hospitality tech vendors, integrators, and SaaS safety platform providers.

Patent data sourced from USPTO via PatSnap Eureka patent database Search patent records in Eureka ↗
Freedom to operate

Should your team run an FTO against US7486194B2?

Any company developing or commercialising staff safety monitoring systems, personnel duress alerting, or connected in-room safety platforms in the hospitality or facilities management sector should assess exposure to US7486194B2. The dismissal of IHTC’s claims against Enseo does not affect the patent’s enforceability against other parties — and IHTC retains the right to assert this patent in new actions against different defendants.

PatSnap Eureka’s FTO Search Agent can map the claim scope of US7486194B2 against your product architecture, identify prior art that may support invalidity arguments, and flag any continuation or related family members that could broaden enforcement risk. R&D and product teams building safety or monitoring features into hospitality or facility management platforms should treat this as a prioritised review given IHTC’s active assertion history.

PatSnap Eureka FTO Search

Run a freedom-to-operate analysis on US7486194B2 to assess your product’s exposure

Run FTO in Eureka →
Related litigation

Similar Patent Cases: Safety Monitoring Tech in E.D. Texas

Related infringement actions asserting safety and monitoring system patents before the Eastern District of Texas, including cases with comparable joint stipulation outcomes.

🔍
Access 40+ similar cases in PatSnap Eureka
International Health Technology Company, LLC patent enforcement history, Texas Eastern case history, International Health Technology Company, LLC’s full IP portfolio, and comparable case analysis
Comparable E.D. Texas outcomesSafety tech patent assertionsFish & Richardson defense winsMadeSafe-adjacent IP cases
Unlock similar cases in Eureka →
Strategic implications

What this case signals for the hospitality and safety tech IP landscape

A with-prejudice dismissal of a patentee’s claims in E.D. Texas typically reflects meaningful litigation risk — or a negotiated exit under pressure.

With-prejudice dismissals signal elevated risk for the patent holder

When a plaintiff accepts dismissal with prejudice in a joint stipulation, it permanently surrenders enforcement rights against that defendant. For IHTC, this closes the door on Enseo entirely. Competitors facing similar assertions from IHTC on US7486194B2 may cite this outcome as evidence of claim vulnerability.

Enseo’s counterclaims preserved — a structural advantage worth monitoring

Retaining counterclaims without prejudice is unusual in fully bilateral dismissals. It suggests Enseo may have raised invalidity or inequitable conduct theories that IHTC was unwilling to litigate to conclusion. IP teams at companies in the safety monitoring and hospitality tech space should track whether Enseo pursues those theories in other forums.

🔒
Full strategic analysis in PatSnap Eureka
Unlock deeper analysis on US7486194B2 enforceability, hospitality tech patent risk, and E.D. Texas district court strategy.
Patent validity signalsEnseo’s counterclaim riskE.D. Texas strategy map
Unlock full analysis →
Analysis powered by PatSnap Eureka Litigation Intelligence Explore in Eureka ↗
Frequently asked questions

International v Enseo — key questions answered

Still have questions? PatSnap Eureka can answer them instantly from patent and litigation data. Ask Eureka ↗
PatSnap Eureka

Track MadeSafe patent risk and monitor IHTC’s next enforcement moves

US7486194B2 remains active and assertable against the market. PatSnap Eureka enables real-time monitoring of IHTC’s enforcement activity, claim scope mapping, and FTO analysis for safety and hospitality technology teams.

Ask anything about this case.
PatSnap Eureka searches patents and litigation data to answer instantly.
Powered by PatSnap Eureka
Link copied to clipboard

Related Litigation Cases

Help us improve this page

Found incorrect or outdated information? Let us know and we'll get it fixed.